Article Text
Editorial
Prior anti-thrombotic drugs and stroke mortality
Statistics from Altmetric.com
Footnotes
Linked articles 301076.
Competing interests MJA has been a speaker for Bristol Myers Squibb, Sanofi-Aventis, Boehringer-Ingelheim, and is a consultant for the above entities as well as Janssen and Pfizer.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
- Antiplatelet therapy